| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 696916 | Null | 0.0375780807984386 | 0.31077707 |
| NSC 13275 | Null | 0.0375780807984392 | 0.248736 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0375780807984392 | 0.31575542 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0375780807984392 | 0.3339623 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.0375780807984392 | 0.36271454 |
| NSC 15795 | Null | 0.0375780807984392 | 0.53891304 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0375780807984392 | 0.22375895 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0375780807984392 | 0.076376852 |
| NSC 346098 | Null | 0.0375780807984392 | 0.18799881 |
| NSC 48526 | Null | 0.0375780807984392 | -0.074077064 |